- Home
- ORMP vs IMAB Comparison
ORMP vs IMAB Comparison
Compare ORMP & IMAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ORMP
- IMAB
- Stock Information
- Founded
- ORMP 2002
- IMAB 2014
- Country
- ORMP United States
- IMAB United States
- Employees
- ORMP N/A
- IMAB N/A
- Industry
- ORMP Biotechnology: Pharmaceutical Preparations
- IMAB Biotechnology: Pharmaceutical Preparations
- Sector
- ORMP Health Care
- IMAB Health Care
- Exchange
- ORMP Nasdaq
- IMAB Nasdaq
- Market Cap
- ORMP N/A
- IMAB 200.9M
- IPO Year
- ORMP N/A
- IMAB 2020
- Fundamental
- Price
- ORMP $2.19
- IMAB $2.45
- Analyst Decision
- ORMP Hold
- IMAB Strong Buy
- Analyst Count
- ORMP 1
- IMAB 2
- Target Price
- ORMP N/A
- IMAB $6.00
- AVG Volume (30 Days)
- ORMP 86.7K
- IMAB 1.2M
- Earning Date
- ORMP 08-15-2025
- IMAB 05-15-2025
- Dividend Yield
- ORMP N/A
- IMAB N/A
- EPS Growth
- ORMP N/A
- IMAB N/A
- EPS
- ORMP N/A
- IMAB N/A
- Revenue
- ORMP $2,000,000.00
- IMAB N/A
- Revenue This Year
- ORMP N/A
- IMAB N/A
- Revenue Next Year
- ORMP N/A
- IMAB N/A
- P/E Ratio
- ORMP N/A
- IMAB N/A
- Revenue Growth
- ORMP 196.74
- IMAB N/A
- 52 Week Low
- ORMP $1.82
- IMAB $0.60
- 52 Week High
- ORMP $3.09
- IMAB $3.08
- Technical
- Relative Strength Index (RSI)
- ORMP 47.76
- IMAB 50.05
- Support Level
- ORMP $2.12
- IMAB $2.35
- Resistance Level
- ORMP $2.25
- IMAB $2.59
- Average True Range (ATR)
- ORMP 0.09
- IMAB 0.35
- MACD
- ORMP -0.00
- IMAB -0.06
- Stochastic Oscillator
- ORMP 50.00
- IMAB 1.86
About IMAB I-MAB
I-MAB is a clinical-stage biotech company. Along with its subsidiaries, it is principally engaged in discovering and developing transformational biologics in the fields of immuno-oncology and immuno-inflammation diseases in the People's Republic of China and other countries and regions. Its drug pipeline includes Uliledlimab (TJD5) which is an antibody for solid tumors, Ragistomig (TJ-L14B), and Givastomig (TJ-CD4B).